Jean Merot

Dr. Jean Merot


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2013 in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Verified
Journal Article
Closed access
PDF file
DDD. Duval
D. Duval
ALA. Lardeux
A. Lardeux
TTT. Le Tourneau
T. Le Tourneau
RNRussell Norris
Russell Norris
RMRoger Markwald
Roger Markwald
JMJean Merot
Jean Merot

Verified
Journal Article
Open access
PDF file
DDDamien Duval
Damien Duval
PLPauline Labbé
Pauline Labbé
LBLéa Bureau
Léa Bureau
TTThierry Le Tourneau
Thierry Le Tourneau
RNRussell Norris
Russell Norris
JMJean Merot
Jean Merot
Although the genetic basis of mitral valve prolapse (MVP) has now been clearly established, the molecular and cellular mechanisms involved in the pathological processes associated to a specific mutation often remain to be determined. The FLNA gene (encoding Filamin A; FlnA) was the first gene associated to non-syndromic X-linked myxomatous valvular dystrophy, but the impacts of the mutations on its function remain un-elucidated. Here, using the first repeats (1–8) of FlnA as a bait in a yeast two-hybrid screen, we identified the tyrosine phosphatase PTPN12 (PTP-PEST) as a specific binding partner of this region of FlnA protein. In addition, using yeast two-hybrid trap assay pull down and co-immunoprecipitation experiments, we showed that the MVP-associated FlnA mutations (G288R, P637Q, H743P) abolished FlnA/PTPN12 interactions. PTPN12 is a key regulator of signaling pathways involved in cell-extracellular matrix (ECM) crosstalk, cellular responses to mechanical stress that involve integrins, focal adhesion transduction pathways, and actin cytoskeleton dynamics. Interestingly, we showed that the FlnA mutations impair the activation status of two PTPN12 substrates, the focal adhesion associated kinase Src, and the RhoA specific activating protein p190RhoGAP. Together, these data point to PTPN12/FlnA interaction and its weakening by FlnA mutations as a mechanism potentially involved in the physiopathology of FlnA-associated MVP.

1 July 2017 in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Verified
Journal Article
Closed access
PLPauline Labbé
Pauline Labbé
EFEmilie Faure
Emilie Faure
SLSimon Lecointe
Simon Lecointe
SSSolena Le Scouarnec
Solena Le Scouarnec
FKFlorence Kyndt
Florence Kyndt
JMJean Merot
Jean Merot

24 August 2022 in Cardiovascular Research
Verified
Journal Article
Closed access
PDF file
CDConstance Delwarde
Constance Delwarde
CTClaire Toquet
Claire Toquet
PAPascal Aumond
Pascal Aumond
AKAmir Hossein Kayvanjoo
Amir Hossein Kayvanjoo
AFAdrien Foucal
Adrien Foucal
RORomain Capoulade Inserm DR Grand Ouest
Romain Capoulade Inserm DR Grand Ouest
Degenerative mitral valve dystrophy (MVD) leading to mitral valve prolapse is the most frequent form of MV disease, and there is currently no pharmacological treatment available. The limited understanding of the pathophysiological mechanisms leading to MVD limits our ability to identify therapeutic targets. This study aimed to reveal the main pathophysiological pathways involved in MVD via the multimodality imaging and transcriptomic analysis of the new and unique knock-in (KI) rat model for the FilaminA-P637Q (FlnA-P637Q) mutation associated-MVD. Wild-type (WT) and KI rats were evaluated morphologically, functionally, and histologically between 3-week-old and 3-to-6-month-old based on Doppler echocardiography, 3D micro-computed tomography (microCT), and standard histology. RNA-sequencing and Assay for Transposase-Accessible Chromatin (ATAC-seq) were performed on 3-week-old WT and KI mitral valves and valvular cells, respectively, to highlight the main signalling pathways associated with MVD. Echocardiographic exploration confirmed MV elongation (2.0 ± 0.1 mm vs. 1.8 ± 0.1, P = 0.001), as well as MV thickening and prolapse in KI animals compared to WT at 3 weeks. 3D MV volume quantified by microCT was significantly increased in KI animals (+58% vs. WT, P = 0.02). Histological analyses revealed a myxomatous remodelling in KI MV characterized by proteoglycans accumulation. A persistent phenotype was observed in adult KI rats. Signalling pathways related to extracellular matrix homeostasis, response to molecular stress, epithelial cell migration, endothelial to mesenchymal transition, chemotaxis and immune cell migration, were identified based on RNA-seq analysis. ATAC-seq analysis points to the critical role of transforming growth factor-β and inflammation in the disease. The KI FlnA-P637Q rat model mimics human myxomatous MVD, offering a unique opportunity to decipher pathophysiological mechanisms related to this disease. Extracellular matrix organization, epithelial cell migration, response to mechanical stress, and a central contribution of immune cells are highlighted as the main signalling pathways leading to myxomatous MVD. Our findings pave the road to decipher underlying molecular mechanisms and the specific role of distinct cell populations in this context.

1 January 2015 in Archives of Cardiovascular Diseases Supplements
Verified
Journal Article
Closed access
ARAntoine Rimbert
Antoine Rimbert
DDDamien Duval
Damien Duval
FKFlorence Kyndt
Florence Kyndt
SLSimon Lecointe
Simon Lecointe
VPVincent Probst
Vincent Probst
JSJean-Jacques Schott
Jean-Jacques Schott

1 April 2016 in Archives of Cardiovascular Diseases Supplements
Verified
Journal Article
Closed access
PLPauline Labbé
Pauline Labbé
ARAntoine Rimbert
Antoine Rimbert
AJAntoine Jobbe-Duval
Antoine Jobbe-Duval
SLSimon Lecointe
Simon Lecointe
SSSolena Le Scouarnec
Solena Le Scouarnec
JMJean Merot
Jean Merot